306
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Γ-aminobutyric acid receptors affect the progression and migration of tumor cells

, , &
Pages 431-439 | Received 07 Mar 2013, Accepted 09 Oct 2013, Published online: 28 Aug 2014

References

  • Sieghart W. Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. Pharmacol Rev 1995;47:181–234
  • Kerr DI, Ong J. GABAB receptors. Pharmacol Ther 1995;67:187–246
  • Jin N, Guo Y, Sun P, et al. Ionotropic GABA receptor expression in the lung during development. Gene Expr Patterns 2008;8:397–403
  • Duncan CE, Webster MJ, Rothmond DA, et al. Prefrontal GABA(A) receptor alpha-subunit expression in normal postnatal human development and schizophrenia. J Psychiatr Res 2010;44:673–81
  • Henschel O, Gipson KE, Bordey A. GABAA receptors, anesthetics and anticonvulsants in brain development. CNS Neurol Disord Drug Targets 2008;7:211–24
  • Soltani N, Qiu H, Aleksic M, et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc Natl Acad Sci U S A 2011;108:11692–7
  • Jin Z, Mendu SK, Birnir B. GABA is an effective immunomodulatory molecule. Amino Acids 2011;45:87–94
  • Lukasiewicz PD, Shields CR. A diversity of GABA receptors in the retina. Semin Cell Dev Biol 1998;9:293–9
  • Watanabe M, Maemura K, Kanbara K, et al. GABA and GABA receptors in the central nervous system and other organs. Int Rev Cytol 2002;213:1–47
  • Azuma H, Inamoto T, Sakamoto T, et al. Gamma-aminobutyric acid as a promoting factor of cancer metastasis; induction of matrix metalloproteinase production is potentially its underlying mechanism. Cancer Res 2003;63:8090–6
  • Thaker PH, Yokoi K, Jennings NB, et al. Inhibition of experimental colon cancer metastasis by the GABA-receptor agonist nembutal. Cancer Biol Ther 2005;4:753–8
  • Watanabe M, Maemura K, Oki K, et al. Gamma-aminobutyric acid (GABA) and cell proliferation: focus on cancer cells. Histol Histopathol 2006;21:1135–41
  • Rotondo A, Serio R, Mule F. Functional evidence for different roles of GABAA and GABAB receptors in modulating mouse gastric tone. Neuropharmacology 2010;58:1033–7
  • Al-Wadei HA, Ullah MF, Al-Wadei M. GABA (gamma-aminobutyric acid), a non-protein amino acid counters the beta-adrenergic cascade-activated oncogenic signaling in pancreatic cancer: a review of experimental evidence. Mol Nutr Food Res 2011;55:1745–58
  • Al-Wadei HA, Al-Wadei MH, Schuller HM. Cooperative regulation of non-small cell lung carcinoma by nicotinic and beta-adrenergic receptors: a novel target for intervention. PLoS One 2012;7:e29915
  • Schuller HM, Al-Wadei HA. Neurotransmitter receptors as central regulators of pancreatic cancer. Future Oncol 2010;6:221–8
  • Young SZ, Bordey A. GABA's control of stem and cancer cell proliferation in adult neural and peripheral niches. Physiology (Bethesda) 2009;24:171–85
  • Schuller HM, Al-Wadei HA, Majidi M. Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma. Carcinogenesis 2008;29:1979–85
  • Roberts SS, Mendonca-Torres MC, Jensen K, et al. GABA receptor expression in benign and malignant thyroid tumors. Pathol Oncol Res 2009;15:645–50
  • Li YH, Liu Y, Li YD, et al. GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit. World J Gastroenterol 2012;18:2704–11
  • Maemura K, Shiraishi N, Sakagami K, et al. Proliferative effects of gamma-aminobutyric acid on the gastric cancer cell line are associated with extracellular signal-regulated kinase 1/2 activation. J Gastroenterol Hepatol 2009;24:688–96
  • Abdul M, McCray SD, Hoosein NM. Expression of gamma-aminobutyric acid receptor (subtype A) in prostate cancer. Acta Oncol 2008;47:1546–50
  • D'Urso PI, D'Urso OF, Storelli C, et al. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. Int J Oncol 2012;41:228–34
  • Ernst M, Bruckner S, Boresch S, Sieghart W. Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function. Mol Pharmacol 2005;68:1291–300
  • Laake JH, Takumi Y, Eidet J, et al. Postembedding immunogold labelling reveals subcellular localization and pathway-specific enrichment of phosphate activated glutaminase in rat cerebellum. Neuroscience 1999;88:1137–51
  • Walls AB, Eyjolfsson EM, Smeland OB, et al. Knockout of GAD65 has major impact on synaptic GABA synthesized from astrocyte-derived glutamine. J Cereb Blood Flow Metab 2011;31:494–503
  • Simon J, Wakimoto H, Fujita N, et al. Analysis of the set of GABA(A) receptor genes in the human genome. J Biol Chem 2004;279:41422–35
  • Goetz T, Arslan A, Wisden W, Wulff P. GABA(A) receptors: structure and function in the basal ganglia. Prog Brain Res 2007;160:21–41
  • Olsen RW, Sieghart W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 2009;56:141–8
  • Gielen MC, Lumb MJ, Smart TG. Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding. J Neurosci 2012;32:5707–15
  • Richter L, de Graaf C, Sieghart W, et al. Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands. Nat Chem Biol 2012;8:455–64
  • Shiratsuchi H, Kouatli Y, Yu GX, et al. Propofol inhibits pressure-stimulated macrophage phagocytosis via the GABAA receptor and dysregulation of p130cas phosphorylation. Am J Physiol Cell Physiol 2009;296:C1400–10
  • Leppa E, Vekovischeva OY, Linden AM, et al. Agonistic effects of the beta-carboline DMCM revealed in GABA(A) receptor gamma 2 subunit F77I point-mutated mice. Neuropharmacology 2005;48:469–78
  • Connolly CN, Krishek BJ, McDonald BJ, et al. Assembly and cell surface expression of heteromeric and homomeric gamma-aminobutyric acid type A receptors. J Biol Chem 1996;271:89–96
  • Lorez M, Benke D, Luscher B, et al. Single-channel properties of neuronal GABAA receptors from mice lacking the 2 subunit. J Physiol 2000;527 Pt 1:11–31
  • Whiting PJ, Bonnert TP, McKernan RM, et al. Molecular and functional diversity of the expanding GABA-A receptor gene family. Ann N Y Acad Sci 1999;868:645–53
  • Bonnert TP, McKernan RM, Farrar S, et al. Theta, a novel gamma-aminobutyric acid type A receptor subunit. Proc Natl Acad Sci U S A 1999;96:9891–6
  • Davies PA, Hanna MC, Hales TG, Kirkness EF. Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit. Nature 1997;385:820–3
  • Rebrov IB, Kryzhanovskii GN, Belykh NP, et al. Effect of muscimol on the delay in desensitization of GABA-receptor/Cl–ionophor complex induced by picrotoxin and bicuculline. Biull Eksp Biol Med 1996;122:144–7
  • Rebrov IG, Kryzhanovskii GN, Belykh NP, et al. The effect of picrotoxin and bicuculline on desensitization of the GABA receptor/Cl-ionophore complex. Biull Eksp Biol Med 1994;118:160–3
  • Ghansah E, Weiss DS. Modulation of GABA(A) receptors by benzodiazepines and barbiturates is autonomous of PKC activation. Neuropharmacology 2001;40:327–33
  • Ng CK, Kim HL, Gavande N, et al. Medicinal chemistry of rho GABAC receptors. Future Med Chem 2011;3:197–209
  • Olsen RW, Sieghart W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 2008;60:243–60
  • Loup F, Picard F, Yonekawa Y, et al. Selective changes in GABAA receptor subtypes in white matter neurons of patients with focal epilepsy. Brain 2009;132:2449–63
  • Singhuber J, Baburin I, Kahlig H, et al. GABA(A) receptor modulators from Chinese herbal medicines traditionally applied against insomnia and anxiety. Phytomedicine 2012;19:334–40
  • Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 2011;16:383–406
  • Strambi C, Cayre M, Sattelle DB, et al. Immunocytochemical mapping of an RDL-like GABA receptor subunit and of GABA in brain structures related to learning and memory in the cricket Acheta domesticus. Learn Mem 1998;5:78–89
  • Benke D. Mechanisms of GABAB receptor exocytosis, endocytosis, and degradation. Adv Pharmacol 2010;58:93–111
  • Pinard A, Seddik R, Bettler B. GABAB receptors: physiological functions and mechanisms of diversity. Adv Pharmacol 2010;58:231–55
  • Adams CL, Lawrence AJ. CGP7930: a positive allosteric modulator of the GABAB receptor. CNS Drug Rev 2007;13:308–16
  • Urwyler S, Gjoni T, Koljatic J, Dupuis DS. Mechanisms of allosteric modulation at GABAB receptors by CGP7930 and GS39783: effects on affinities and efficacies of orthosteric ligands with distinct intrinsic properties. Neuropharmacology 2005;48:343–53
  • Binet V, Brajon C, Le Corre L, et al. The heptahelical domain of GABA(B2) is activated directly by CGP7930, a positive allosteric modulator of the GABA(B) receptor. J Biol Chem 2004;279:29085–91
  • Bettler B, Kaupmann K, Mosbacher J, Gassmann M. Molecular structure and physiological functions of GABA(B) receptors. Physiol Rev 2004;84:835–67
  • Kaupmann K, Huggel K, Heid J, et al. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature 1997;386:239–46
  • Lee C, Mayfield RD, Harris RA. Intron 4 containing novel GABAB1 isoforms impair GABAB receptor function. PLoS One 2010;5:e14044
  • Jiang X, Su L, Zhang Q, et al. GABAB receptor complex as a potential target for tumor therapy. J Histochem Cytochem 2012;60:269–79
  • Pagano A, Rovelli G, Mosbacher J, et al. C-terminal interaction is essential for surface trafficking but not for heteromeric assembly of GABA(b) receptors. J Neurosci 2001;21:1189–202
  • Vigot R, Barbieri S, Brauner-Osborne H, et al. Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron 2006;50:589–601
  • Bettler B, Tiao JY. Molecular diversity, trafficking and subcellular localization of GABAB receptors. Pharmacol Ther 2006;110:533–43
  • Blein S, Ginham R, Uhrin D, et al. Structural analysis of the complement control protein (CCP) modules of GABA(B) receptor 1a: only one of the two CCP modules is compactly folded. J Biol Chem 2004;279:48292–306
  • Tiao JY, Bradaia A, Biermann B, et al. The sushi domains of secreted GABA(B1) isoforms selectively impair GABA(B) heteroreceptor function. J Biol Chem 2008;283:31005–11
  • Perez-Garci E, Gassmann M, Bettler B, Larkum ME. The GABAB1b isoform mediates long-lasting inhibition of dendritic Ca2+ spikes in layer 5 somatosensory pyramidal neurons. Neuron 2006;50:603–16
  • Martin SC, Russek SJ, Farb DH. Human GABA(B)R genomic structure: evidence for splice variants in GABA(B)R1 but not GABA(B)R2. Gene 2001;278:63–79
  • Isomoto S, Kaibara M, Sakurai-Yamashita Y, et al. Cloning and tissue distribution of novel splice variants of the rat GABAB receptor. Biochem Biophys Res Commun 1998;253:10–15
  • Schwarz DA, Barry G, Eliasof SD, et al. Characterization of gamma-aminobutyric acid receptor GABAB(1e), a GABAB(1) splice variant encoding a truncated receptor. J Biol Chem 2000;275:32174–81
  • Wei K, Eubanks JH, Francis J, et al. Cloning and tissue distribution of a novel isoform of the rat GABA(B)R1 receptor subunit. Neuroreport 2001;12:833–7
  • Wei K, Jia Z, Wang YT, et al. Cloning and characterization of a novel variant of rat GABA(B)R1 with a truncated C-terminus. Brain Res Mol Brain Res 2001;89:103–10
  • Holter J, Davies J, Leresche N, et al. Identification of two further splice variants of GABABR1 characterizes the conserved micro-exon 4 as a hot spot for regulated splicing in the rat brain. J Mol Neurosci 2005;26:99–108
  • Calver AR, Robbins MJ, Cosio C, et al. The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J Neurosci 2001;21:1203–10
  • Helm KA, Haberman RP, Dean SL, et al. GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the cAMP response element (CRE) in the hippocampus. Neuropharmacology 2005;48:956–64
  • Metz M, Gassmann M, Fakler B, et al. Distribution of the auxiliary GABAB receptor subunits KCTD8, 12, 12b, and 16 in the mouse brain. J Comp Neurol 2011;519:1435–54
  • Chalifoux JR, Carter AG. GABAB receptor modulation of voltage-sensitive calcium channels in spines and dendrites. J Neurosci 2011;31:4221–32
  • Couve A, Moss SJ, Pangalos MN. GABAB receptors: a new paradigm in G protein signaling. Mol Cell Neurosci 2000;16:296–312
  • Smits A, Jin Z, Elsir T, et al. GABA-A channel subunit expression in human glioma correlates with tumor histology and clinical outcome. PLoS One 2012;7:e37041
  • Drell TL 4th, Joseph J, Lang K, et al. Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 2003;80:63–70
  • Wang T, Huang W, Chen F. Baclofen, a GABAB receptor agonist, inhibits human hepatocellular carcinoma cell growth in vitro and in vivo. Life Sci 2008;82:536–41
  • Lodewyks C, Rodriguez J, Yan J, et al. GABA-B receptor activation inhibits the in vitro migration of malignant hepatocytes. Can J Physiol Pharmacol 2011;89:393–400
  • Fava G, Marucci L, Glaser S, et al. gamma-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway. Cancer Res 2005;65:11437–46
  • Minuk GY, Zhang M, Gong Y, et al. Decreased hepatocyte membrane potential differences and GABAA-beta3 expression in human hepatocellular carcinoma. Hepatology 2007;45:735–45
  • Liu Y, Li YH, Guo FJ, et al. Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. World J Gastroenterol 2008;14:7175–82
  • Schuller HM, Al-Wadei HA, Majidi M. GABA B receptor is a novel drug target for pancreatic cancer. Cancer 2008;112:767–78
  • Takehara A, Hosokawa M, Eguchi H, et al. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit. Cancer Res 2007;67:9704–12
  • Joseph J, Niggemann B, Zaenker KS, Entschladen F. The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cells. Cancer Res 2002;62:6467–9
  • Nicholson-Guthrie CS, Guthrie GD, Sutton GP, Baenziger JC. Urine GABA levels in ovarian cancer patients: elevated GABA in malignancy. Cancer Lett 2001;162:27–30
  • Szczaurska K, Mazurkiewicz M, Opolski A. The role of GABA-ergic system in carcinogenesis. Postepy Hig Med Dosw 2003;57:485–500
  • Lages E, Ipas H, Guttin A, et al. MicroRNAs: molecular features and role in cancer. Front Biosci 2012;17:2508–40
  • Liu Y, Guo F, Dai M, et al. Gammaaminobutyric acid A receptor alpha 3 subunit is overexpressed in lung cancer. Pathol Oncol Res 2009;15:351–8
  • Garib V, Lang K, Niggemann B, et al. Propofol-induced calcium signalling and actin reorganization within breast carcinoma cells. Eur J Anaesthesiol 2005;22:609–15
  • Uganda Community Based Health Care Association. General Meeting (10th: 1995: Kampala Uganda). UCBHCA in a changing environment: proceedings of the Tenth Annual General Meeting; 1995 Nov 2–3; Kampala
  • Ippolito JE, Merritt ME, Backhed F, et al. Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers. Proc Natl Acad Sci U S A 2006;103:12505–10
  • Broiz AC, Bassi GS, De Souza Silva MA, Brandao ML. Effects of neurokinin-1 and 3-receptor antagonists on the defensive behavior induced by electrical stimulation of the dorsal periaqueductal gray. Neuroscience 2012;201:134–45
  • Inoue K, Shirai T, Ochiai H, et al. Blood-pressure-lowering effect of a novel fermented milk containing gamma-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 2003;57:490–5
  • Wong CG, Bottiglieri T, Snead OC 3rd. GABA, gamma-hydroxybutyric acid, and neurological disease. Ann Neurol 2003;54:S3–12
  • Hagiwara H, Seki T, Ariga T. The effect of pre-germinated brown rice intake on blood glucose and PAI-1 levels in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem 2004;68:444–7
  • Leggio L, Zywiak WH, McGeary JE, et al. A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacol Biochem Behav 2013;103:784–91
  • Geffen Y, Keefe R, Rabinowitz J, et al. Bl-1020, a new gamma-aminobutyric acid-enhanced antipsychotic: results of 6-week, randomized, double-blind, controlled, efficacy and safety study. J Clin Psychiatry 2012;73:e1168–74
  • Zhang X, Zhang R, Zheng Y, et al. Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med 2013;11:102

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.